Eledon Pharmaceuticals (ELDN) Competitor Comparison
We are evaluating the key criteria listed to compare Eledon Pharmaceuticals (ELDN) against its competitors in the Biotechnology industry.
Market Capitalization
301 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
0 / 337Free Cashflow
153 / 352Quick Ratio
24 / 357Earnings per Share
28 / 359Dividend yield
0 / 6Total Cash
250 / 358Performance 3 years
118 / 368Performance 5 years
197 / 368Performance 10 years
349 / 368Linearity 3 years
53 / 368Linearity 5 years
160 / 368Linearity 10 years
310 / 368Total Rank
18 / 368Dividend Rank
117 / 368Valuation Rank
56 / 368Piotroski Rank
229 / 368Muliplier Rank
8 / 368Linearity 5 years - ELDN ranking 160 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.